News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  8 September 2014  
  Mass spectrometry based quantitative proteomics and integrative network analysis accentuates modulating roles of annexin-1 in mammary tumorigenesis
 
 




Authors
Hannah L. F. Swa1, Asfa Alli Shaik1, Lina H. K. Lim2 and Jayantha Gunaratne1,3

Quantitative Proteomics Group, Institute of Molecular and Cell Biology, Agency for Science, Technology   and Research, Singapore
Department of Physiology and 3 Department of Anatomy, Yong Loo Lin School of Medicine, National   University of Singapore, Singapore

Published in Proteomics on 13 Aug 2014.

Abstract
Annexin-1 (ANXA1) is known to be involved in important cellular processes and implicated in cancer. Our previous study showed its roles in cell migration and DNA-damage response processes in breast cancer initiation. In order to understand its roles in tumorigenesis, we extended our studies to analyze tumors derived from Polyomavirus Middle T-Antigen (PyMT) ANXA1-heterozygous (ANXA1+/- ) and null (ANXA1-/- ) mice. We performed quantitative comparison of ANXA1+/- and ANXA1-/- tumors employing reductive dimethyl labelling quantitative proteomics. We observed 253 differentially-expressed proteins (DEPs) with high statistical significance among over 5000 quantified proteins. Combinatorial use of pathway and network-based computational analyses of the DEPs revealed that ANXA1 primarily modulates processes related to cytoskeletal remodelling and immune responses in these mammary tumors. Of particular note, ANXA1-/- tumor showed reduced expression of a known epithelial-mesenchymal transition (EMT) marker Vimentin (VIM), as well as myosin light chain kinase (MLCK), which has been reported to induce Rho-kinase mediated assembly of stress fibres known to be implicated in EMT. Integrative network analysis of established interactome of ANXA1 alongside with DEPs further highlights the involvement of ANXA1 in EMT. Functional role of ANXA1 in tumorigenesis was established in invasion assay where knocking down ANXA1 in murine mammary tumor cell line 168FARN showed lower invasive capability. Altogether, this study emphasizes that ANXA1 plays modulating roles contributing to invasion-metastasis in mammary tumorigenesis, distinctive to its roles in cancer initiation.

Figure Legend:
Comprehensive network mapping of the ANXA1-regulated proteins. Functional interactions among the down-regulated proteins alongside with the downstream interactors of ANXA1 are represented. The reconstructed network combines individual protein-protein interactions obtained from STRING and those pathway-informed interactions obtained from MetaCore. Individual functional clusters identified based on biological process enrichment are shown in the dotted circles. The nodes and edges are differently colored according to the function of protein and type of interactions involved.

For more information on Quantitative Proteomics Group, please click here.